Literature DB >> 4625182

The pattern of resistance development to rifampicin in Mycobacterium tuberculosis.

M Tsukamura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4625182     DOI: 10.1016/0041-3879(72)90027-x

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


× No keyword cloud information.
  9 in total

Review 1.  Treatment of pulmonary disease caused by opportunist mycobacteria.

Authors:  J Banks
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

2.  Permeability barrier to rifampin in mycobacteria.

Authors:  J Hui; N Gordon; R Kajioka
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

3.  Genetic analysis of Staphylococcus aureus RNA polymerase mutants.

Authors:  T O Morrow; S A Harmon
Journal:  J Bacteriol       Date:  1979-01       Impact factor: 3.490

4.  Resistance to rifampicin and isoniazid in strains of Mycobacterium tuberculosis.

Authors:  S H Siddiqi; A Aziz; Z Reggiardo; G Middlebrook
Journal:  J Clin Pathol       Date:  1981-08       Impact factor: 3.411

5.  Comparison of antibacterial and antiimmune effects of certain rifamycins.

Authors:  J E Kasik; M Monick
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

6.  Mycobacterium tuberculosis resistance to rifampicin and ethambutol: a clinical survey.

Authors:  J B Macdonald
Journal:  Thorax       Date:  1977-02       Impact factor: 9.139

7.  The rpoB gene of Mycobacterium tuberculosis.

Authors:  L P Miller; J T Crawford; T M Shinnick
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

8.  In-depth molecular characterization of Mycobacterium tuberculosis from New Delhi--predominance of drug resistant isolates of the 'modern' (TbD1) type.

Authors:  Ruth Stavrum; Vithal Prasad Myneedu; Virendra K Arora; Niyaz Ahmed; Harleen M S Grewal
Journal:  PLoS One       Date:  2009-02-23       Impact factor: 3.240

9.  Rifampicin-resistant Mycobacterium leprae in an elderly leprosy patient in the people's Republic of China.

Authors:  Meiwen Yu; Kan Wu; Bing Pei; Degang Yang; Qiulin Wang; Hongsheng Wang; Jianping Shen; Liangbing Yan; Guochen Zhang
Journal:  Clin Interv Aging       Date:  2013-08-21       Impact factor: 4.458

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.